Neurotoxic effects of methamphetamine

Neurochemical Research

Volumn 35, Issue 1, 2010, Pages 171-179

  Thrash, Bessy ^a   Karuppagounder, Senthilkumar S ^a   Uthayathas, Subramaniam ^a   Suppiramaniam, Vishnu ^a   Dhanasekaran, Muralikrishnan ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

Behavior; Dopamine; Methamphetamine; Neurotoxicity; Oxidative stress; Parkinson's disease

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); DOPAMINE; METHAMPHETAMINE; REACTIVE OXYGEN METABOLITE;

AKINESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATALEPSY; CONTROLLED STUDY; CORPUS STRIATUM; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOPAMINE BRAIN LEVEL; ELECTROCHEMICAL DETECTION; ENZYME ACTIVITY; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MOUSE; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEPLETION; SCORING SYSTEM; SWIMMING;

ANIMALS; BEHAVIOR, ANIMAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORPUS STRIATUM; ELECTROCHEMISTRY; MALE; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; MONOAMINE OXIDASE; REACTIVE OXYGEN SPECIES; SUBSTANTIA NIGRA;

EID: 76849098499     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-009-0042-5     Document Type: Article

References (47)

1. O Hornykiewicz 1973 Parkinson's disease: from brain homogenate to treatment Fed Proc 32 183 190 1:CAS:528:DyaE3sXot1KhsQ%3D%3D 4143953
2. DB Caine JW Langston 1983 Aetiology of Parkinson's disease Lancet 2 1457 1459
3. VH Sethy BR Ellerbrock H Wu 1997 U-95666E: A potential anti-parkinsonian drug with anxiolytic activity Prog Neuro-Psychopharmacol Biol Psychiat 21 873 883 10.1016/S0278-5846(97)00086-9 1:CAS:528:DyaK2sXlsFWqsr4%3D (Pubitemid 27326929)
4. IJ Kopin 1992 Parkinson's disease: past, present and future Neuropsycho-pharmacol 9 1 12
5. CD Marsden 1994 Parkinson's disease J Neurol Neurosurg Psych 57 672 681 10.1136/jnnp.57.6.672 1:STN:280:DyaK2c3nsFCltQ%3D%3D
6. EL Riddle AE Fleckenstein GR Hanson 2006 Mechanisms of methamphetamine-induced dopaminergic neurotoxicity AAPS J 8 E413 E418 16808044
7. T Kita GC Wagner T Nakashima 2003 Current research on methamphetamine-induced oxidative stress in cultured mouse astrocytes J Pharmacol Sci 92 178 195 10.1254/jphs.92.178 1:CAS:528:DC%2BD3sXlvFyqtr8%3D 12890883
8. JW Lau S Senok A Stadlin 2000 Methamphetamine-induced oxidative stress in cultured mouse astrocytes Ann N Y Acad Sci 914 146 156 1:CAS:528: DC%2BD3cXosVaksbw%3D 11085317
9. MR Gluck LY Moy E Jayatilleke, et al. 2001 Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment J Neurochem 79 152 160 10.1046/j.1471-4159.2001.00549. x 1:CAS:528:DC%2BD3MXnsV2isb0%3D 11595767 (Pubitemid 32946652)
10. MJ LaVoie JP Card TG Hastings 2004 Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity Exp Neurol 187 47 57 10.1016/j.expneurol.2004.01.010 1:CAS:528:DC%2BD2cXjtVChtrk%3D 15081587 (Pubitemid 38470011)
11. DM Thomas PD Walker JA Benjamins, et al. 2004 Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation J Pharmacol Exp Ther 311 1 7 10.1124/jpet.104.070961 1:CAS:528:DC%2BD2cXosVKrsb4%3D 15163680 (Pubitemid 39287777)
12. DE Dluzen JL McDermott LI Anderson 2001 Tamoxifen diminishes methamphetamine-induced striatal dopamine depletion in intact female and male mice J Neourendocrinol 13 618 624 10.1046/j.1365-2826.2001.00675.x 1:CAS:528:DC%2BD3MXkvFCnt7g%3D (Pubitemid 32591050)
13. TB Sherer JH Kim R Betarbet, et al. 2003 Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation Exp Neurol 179 1 9 16 10.1006/exnr.2002.8072 1:CAS:528: DC%2BD38Xps12ku74%3D 12504863 (Pubitemid 36062614)
14. TM Dawson VL Dawson 2003 Molecular pathways of neurodegeneration in Parkinson's disease Science 302 5646 819 822 10.1126/science.1087753 1:CAS:528:DC%2BD3sXos1Cmt7w%3D 14593166 (Pubitemid 37339614)
15. NIDA Research Report (2002) Methamphetamine abuse and addiction. http://www.nida.nih.gov/PDF/RRMetham.pdf
16. B McMillen 1983 CNS stimulants: two distinct mechanisms of action for amphetamine like drugs TIPS 4 429 432 1:CAS:528:DyaL3sXls1yqsLo%3D
17. C Davidson AJ Gow TH Lee, et al. 2001 Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment Brain Res Rev 36 1 22 10.1016/S0165-0173(01)00054-6 1:CAS:528: DC%2BD3MXmtFSqu7Y%3D 11516769 (Pubitemid 32763126)
18. JL Cadet S Jayanthi X Deng 2003 Speed kills: cellular and molecular basis of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis FASEB J 17 1775 1788 10.1096/fj.03-0073rev 1:CAS:528:DC%2BD3sXot1Kgu70%3D 14519657 (Pubitemid 37214772)
19. JM Wilson KS Kalasinsky AI Levey, et al. 1996 Striatal dopamine nerve terminal markers in human, chronic methamphetamine users Nature Med 2 699 703 10.1038/nm0696-699 1:CAS:528:DyaK28XjsVSjurw%3D 8640565 (Pubitemid 26191961)
20. SC Bondy SF Ali MT Kleinman 2000 Exposure of mice to tobacco smoke attenuates the toxic effect of methamphetamine on dopamine systems Toxicol let 118 43 46 10.1016/S0378-4274(00)00267-8 1:CAS:528:DC%2BD3MXnslWmtQ%3D%3D (Pubitemid 32008392)
21. HC Fibiger EG Mogeer 1971 Effect of acute and chronic methamphetamine treatment on tyrosine hydroxylase activity in brain and adrenal medulla Eur J Pharmaco 16 176 180 10.1016/0014-2999(71)90008-2 1:CAS:528:DyaE38XpsVOnsw%3D%3D
22. SZ Imam J el-Yazal GD Newport, et al. 2001 Methamphetamine-induced dopaminergic neurotoxicity: role of peroxynitrite and neuroprotective role of antioxidants and peroxynitrite decomposition catalysts Ann N Y Acad Sci 939 366 380 1:CAS:528:DC%2BD3MXlsV2ksLk%3D 11462792
23. D Pubill C Chipana A Camins, et al. 2005 Free radical production induced by methamphetamine in rat striatal synaptosomes Toxicol Appl Pharmacol 204 57 68 10.1016/j.taap.2004.08.008 1:CAS:528:DC%2BD2MXisVClt7s%3D 15781294 (Pubitemid 40387567)
24. FB Weihmuller M Hadjiconstantinou JP Bruno 1988 Acute stress or neuroleptics elicit sensorimotor deficits in MPTP-treated mice Neurosci Lett 85 1 137 142 10.1016/0304-3940(88)90443-0 1:CAS:528:DyaL1cXhsVyhtr8%3D 3258974 (Pubitemid 18053454)
25. D Muralikrishnan KP Mohanakumar 1998 Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced neurotoxicity in mice FASEB J 12 905 912 1:CAS:528:DyaK1cXktlCrsro%3D 9657530
26. GA Donnan GL Willis SJ Kaczmarczyk, et al. 1987 Motor function in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-treated mouse J Neurol Sci 77 2-3 185 191 10.1016/0022-510X(87)90121-3 1:CAS:528:DyaL2sXhslSnsb0%3D 3493329
27. S Uthayathas SS Karuppagounder SI Tamer K Parameshwaran T Degim V Suppiramaniam M Dhanasekaran 2007 Evaluation of neuroprotective and anti-fatigue effects of sildenafil Life Sci 81 988 992 10.1016/j.lfs.2007.07.018 1:CAS:528:DC%2BD2sXhtVCmur7O 17825848 (Pubitemid 47384783)
28. D Muralikrishnan M Ebadi 2001 SKF-38393, a dopamine receptor agonist, attenuates 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine- induced neurotoxicity Brain Res 892 241 10.1016/S0006-8993(00)02994-2 1:CAS:528:DC%2BD3MXhtFSmt7c%3D 11172770 (Pubitemid 32141209)
29. RR Ramsay JI Salach J Dadgar, et al. 1986 Inhibition of mitochondrial NADH dehydrogenase by pyridine derivatives and its possible relation to experimental and idiopathic parkinsonism Biochem Biophys Res Commun 135 269 275 10.1016/0006-291X(86)90972-1 1:CAS:528:DyaL28Xhs1Kgt7g%3D 3485428
30. DC Wharton A Tzagotoff 1967 Cytochrome oxidase from beef heart mitochondria Methods Enzymol 10 245 250 10.1016/0076-6879(67)10048-7 1:CAS:528:DyaF1MXnsVGitg%3D%3D
31. M Dhanasekaran B Tharakan BV Manyam 2008 Anti-Parkinson Drug-Mucuna pruriens shows antioxidant and metal chelating activity Phytother Res 22 6 11 10.1002/ptr.2109 1:CAS:528:DC%2BD1cXitFKku70%3D 18064727 (Pubitemid 351155904)
32. Z Xie GM Miller 2009 A receptor mechanism for Methamphetamine action in dopamine transporter regulation in Brain J Pharmacol Exp Ther 208 203 209
33. AH Stokes TG Hastings KE Vrana 1999 Cytotoxic and genotoxic potential of dopamine J Neurosci Res 55 659 665 10.1002/(SICI)1097-4547(19990315)55:6<659: :AID-JNR1>3.0.CO;2-C 1:CAS:528:DyaK1MXisVKku7Y%3D 10220107 (Pubitemid 29173480)
34. JPQ Zhu W Xu JA Angulo 2006 Methamphetamine induced cell death: selective vulnurerability in neuronal subpopulations of the striatum in mice Neuropharmacol 140 2 607 622 1:CAS:528:DC%2BD28Xks1WrsL0%3D
35. S Stephans B Yamamoto 1996 Methamphetamine pretreatment and the vulnerability of the striatum to methamphetamine neurotoxicity Neurosci 72 3 593 600 10.1016/0306-4522(95)00587-0 1:CAS:528:DyaK28Xislyntrk%3D (Pubitemid 26124688)
36. BK Yamamoto W Zhu 1998 The effects of methamphetamine on the production of free radicals and oxidative stress J Pharmacol Exp Ther 287 107 114 1:CAS:528:DyaK1cXmvVSqtb8%3D 9765328
37. C Harold T Wallace R Friedman G Gudelsky B Yamamoto 2000 Methamphetamine selectively alters brain glutathione Eur J Pharmacol 400 99 102 10.1016/S0014-2999(00)00392-7 1:CAS:528:DC%2BD3cXksFGitbo%3D 10913590 (Pubitemid 30412114)
38. KB Burrows G Gudelsky BK Yamamoto 2000 Rapid and transient inhibition of mitochondrial function following methamphetamine or 3, 4- methylenedioxymethamphetamine administration Eur J Pharmacol 398 11 18 10.1016/S0014-2999(00)00264-8 1:CAS:528:DC%2BD3cXktVSmurw%3D 10856443 (Pubitemid 30336672)
39. S Fahn G Cohen 1992 The oxidant stress hypothesis in Parkinson's disease: evidence supporting it Ann Neurol 32 804 812 10.1002/ana.410320616 1:STN:280:DyaK3s7htFOjtQ%3D%3D 1471873
40. P Jenner 1998 Oxidative mechanisms in niagral cell death in Parkinson's disease Mov Discord 13 24 34
41. Cohen G (1988) Oxygen radicals and Parkinson's disease. In Haliwell B (ed) Oxygen Radicals and Tissue Injury. Fed Am Soc Exp Bio, Bethesda, Maryland 130-135
42. R Imberti AL Nieminen B Herman, et al. 1993 Mitochondrial and glycolytic dysfunction in lethal injury to hepatocytes by t-butylhydroperoxide: protection by fructose, cyclosporin A and trifluoperazine J Pharmacol Exp Ther 265 392 400 1:CAS:528:DyaK3sXktVSqsrw%3D 8474021
43. GM Jones JA Vale 2000 Mechanisms of toxicity, clinical features, and management of diquat poisoning: a review J Toxicol Clin Toxicol 38 2 123 128 10.1081/CLT-100100926 1:CAS:528:DC%2BD3cXjtFWqs7o%3D 10778908 (Pubitemid 30212833)
44. Y Akaneya M Takahashi H Hatanaka 1995 Involvement of free radicals in MPP + neurotoxicity against rat dopaminergic neurons in culture Neurosci Lett 193 1 53 56 10.1016/0304-3940(95)11668-M 1:CAS:528:DyaK2MXms1yqtrw%3D 7566666
45. CW Shults 2005 Therapeutic role of coenzyme Q10 in Parkinson's disease Pharmacol Ther 107 120 130 10.1016/j.pharmthera.2005.02.002 1:CAS:528: DC%2BD2MXlt1Ghurs%3D 15963354 (Pubitemid 40800410)
46. B Halliwell 1989 Free radicals, reactive oxygen species and human disease: a critical evaluation with special reference to atherosclerosis Br J Exp Pathol 70 737 757 1:STN:280:DyaK3c7gsFaitg%3D%3D 2557883
47. RG Fariello O Ghilardi A Peschechera, et al. 1988 Regional distribution of ubiquinones and tocopherols in the mouse brain: lowest content of ubiquinols in the substantia nigra Neuropharmacology 27 1077 1080 10.1016/0028-3908(88) 90071-8 1:CAS:528:DyaL1MXltFSi 3237316 (Pubitemid 18241810)